Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07850063) titled 'ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Boehringer Ingelheim
Condition:
Obesity
Metabolic Dysfunction-associated Steatotic Liver Disease
Intervention:
Combination Product: Survodutide
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enro...